Unihealth Hospitals Ltd
NSE: UNIHEALTH · Other · sector
₹551.00NSE close 2026-10-26
Key numbers
Market cap₹865 cr
Price₹551.00
52w high / low₹820 / ₹154
P/E33.0xSector median 14.4x
P/B6.3xSector median 1.7x
Book value₹87.7
Dividend yield–Sector median 0.37%
ROE22.9%Sector median 13.8%
ROCE30.6%Sector median 19.6%
OPM40.8%Sector median 10.4%
Debt / equity0.15xSector median 0.29x
EV/EBITDA16.3xSector median 8.4x
Interest cover20.8x
Current ratio5.33x
Sales growth 3y–Sector median +7.7%
Profit growth 3y–Sector median +16.6%
PEG–
Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹10 cr vs borrowings ₹21 cr (FY26): borrowings are higher by ₹11 cr.
- Operating profit covered interest 20.8x in the last 12 months.
- Operating cash flow was below net profit in 3 of the last 3 years (FY26, FY25, FY24).
- Other income was 19% of net profit in the last 12 months.
- No dividend in the last 3 financial years.
- Price ₹551.00 on 2026-10-26: -32.8% from the 52-week high, +258.8% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹779.35 · low ₹131.00
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 27 | 24 | 32 | 67 | 65 |
| EBITDA | 10 | 8 | 11 | 32 | 22 |
| OPM % | 39.3% | 33.4% | 33.1% | 47.6% | 33.8% |
| Other income | 1 | 1 | 1 | 3 | 2 |
| Net profit | 6 | 5 | 10 | 15 | 11 |
| EPS (₹) | 3.94 | 3.39 | 6.44 | 9.80 | 6.92 |
| Revenue YoY | +145.1% | ||||
| Profit YoY | +76.9% |
Consolidated figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|
| Revenue | 49 | 56 | 132 | 132 |
| EBITDA | 18 | 18 | 54 | 54 |
| Net profit | 10 | 15 | 26 | 26 |
| EPS (₹) | 7.67 | 9.83 | 16.67 | 16.67 |
| Revenue growth | +14.0% | +137.4% | – | |
| Profit growth | +46.8% | +70.6% | – | |
| Dividend / share (₹) | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | +75.3% (2y) | +193.3% |
Balance sheet
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Shareholders' equity | – | 88 | 138 |
| Borrowings | – | – | 21 |
| Cash & equivalents | – | 15 | 10 |
| Total assets | – | 132 | 254 |
| Fixed assets | – | 33 | 65 |
| Capital work in progress | – | – | 10 |
| Investments | – | 0 | 0 |
| Receivables | – | – | 123 |
| Inventory | – | 2 | 7 |
| Payables | – | – | 9 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash from operations | 5 | -3 | 6 |
| Cash from investing | -2 | -4 | -24 |
| Cash from financing | 22 | -3 | 16 |
| Capex | 0 | 10 | 31 |
| Free cash flow | 5 | -13 | -26 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| ROE % | – | 17.2% | 18.8% |
| ROCE % | – | 21.4% | 30.6% |
| Debtor days | – | – | 341 |
| Inventory days | – | 64 | 96 |
| Payable days | – | – | 132 |
| Cash conversion cycle (days) | – | – | 305 |
| Working capital days | – | 366 | 350 |
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| UNIHEALTH | ₹865 cr | 33.0x | 6.3x | 22.9% | 30.6% | 40.8% | – | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Uganda | ₹115 cr | 79.0% | ₹44 cr | 37.9% |
| India | ₹25 cr | 17.1% | ₹-1 cr | -3.6% |
| UAE | ₹4 cr | 3.0% | ₹4 cr | 95.3% |
| Nigeria | ₹1 cr | 0.5% | ₹-0 cr | -27.2% |
| Mauritius | ₹0 cr | 0.2% | ₹0 cr | 10.1% |
| Tanzania | ₹0 cr | 0.1% | ₹-0 cr | -270.8% |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | UNIHEALTH |
| BSE code | – |
| ISIN | INE0PRF01011 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.